Clover Biopharmaceuticals, Ltd. (2197.HK) HKSE

2.33

+0.09(+4.02%)

Updated at October 20 11:59AM

Currency In HKD

Valuation

Market Cap283.77M
Enterprise Value-27.83M
P/E Ratio-3.01
PEG Ratio-0.03
Price/Sales Ratio54.44
Price/Book Ratio-1.6
Enterprise/Revenue47.33
Enterprise/EBITDA-2.78

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-17.57
Operating Margin-17.54

Management Effectiveness

Return On Assets-1.53
Return On Equity0.54

Income Statement

Revenue38.42M
Revenue/Share0.04
Gross Profit-672.94M
EBITDA-916.54M
Net Income-903.43M
Diluted EPS-0.72

Balance Sheet

Total Cash395.74M
Total Cash/Share0.3
Total Debt13.05M
Total Debt/Equity-0.01
Current Ratio0.26
Book Value Per Share-1.36

Price History

52-Week Change618.18
52-Week High3.18
52-Week Low0.19
Moving Average 50 Days1.68
Moving Average 200 Days0.63

Statistics

Average Volume25.03M
Shares Outstanding1.3B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A